FAXDC2 inhibits the proliferation and invasion of human liver cancer HepG2 cells.

"Competing interests The authors declare that they have no competing interests."

"Funding: The present study was supported in part by grants from the National Natural Science Foundation of China (grant nos. 81970324 and 81974019), Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences, East China Normal University, National Key Research and Development Program of China (grant no. 2018YFA0108700), Guangdong Provincial Special Support Program for Prominent Talents (grant no. 2021JC06Y656), Science and Technology Planning Project of Guangdong Province (grant nos. 2020B1111170011 and 2022B1212010010), Guangdong special funds for science and technology innovation strategy, China (Stability support for scientific research institutions affiliated to Guangdong Province- grant no. GDCI 2021), the Marine Economy Development Project of Department of Natural Resources of Guangdong Province [grant no. GDNRC(2022)039], Guangzhou Science and Technology Plan Project (grant no. 202201000006) and the Special Project of Dengfeng Program of Guangdong Provincial People's Hospital (grant no. KJ012019119)."